Quarterly report [Sections 13 or 15(d)]

Selected Financial Statement - Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details)

v3.25.1
Selected Financial Statement - Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Accounts payable:    
Clinical and regulatory expenses $ 514 $ 452
Professional fees 608 904
Selling expenses 1,516 1,553
Manufacturing costs 695 706
Non-employee director compensation 954 966
Other vendors 520 594
Total accounts payable 4,807 5,175
Accrued interest payable, related parties 1,274 1,145
Accrued interest payable 3,492 2,874
Accrued expenses:    
Payroll expenses 466 323
Government rebates and other rebates 7,809 7,229
Due to customers   15
Other accrued expenses 465 165
Total accrued expenses 8,740 7,732
Total accounts payable and accrued expenses $ 18,313 $ 16,926